Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-21 4:21 pm Sale |
2024-02-19 | 13D | Icosavax, Inc. ICVX |
Qiming U.S. Healthcare GP II LLC | 0 0.000% |
-3,523,561 (Position Closed) |
Filing History |
| 2024-02-21 4:17 pm Sale |
2024-02-19 | 13D | Icosavax, Inc. ICVX |
RA Capital Management, L.P. | 0 0.000% |
-5,985,843 (Position Closed) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Icosavax, Inc. ICVX |
Citadel Advisors LLC | 283,079 0.600% |
-1,906,390 (-87.07%) |
Filing History |
| 2024-02-14 4:01 pm Purchase |
2023-12-31 | 13G | Icosavax, Inc. ICVX |
Pentwater Capital Management LP | 3,000,000 5.900% |
3,000,000 (New Position) |
Filing History |
| 2024-02-14 10:04 am Sale |
2023-12-31 | 13G | Icosavax, Inc. ICVX |
T. Rowe Price Investment Management, Inc. | 3,926,407 7.800% |
-537,118 (-12.03%) |
Filing History |
| 2024-02-13 10:37 am Sale |
2023-12-31 | 13G | Icosavax, Inc. ICVX |
PLATINUM ASSET MANAGEMENT LTD | 1,380,618 2.440% |
-869,093 (-38.63%) |
Filing History |
| 2024-02-07 5:09 pm Sale |
2024-01-31 | 13G | Icosavax, Inc. ICVX |
BLACKROCK INC BLK |
2,467,810 4.900% |
-113,720 (-4.41%) |
Filing History |
| 2024-02-02 3:57 pm Purchase |
2023-12-31 | 13G | Icosavax, Inc. ICVX |
BLACKROCK INC BLK |
2,581,530 5.200% |
2,581,530 (New Position) |
Filing History |
| 2024-01-10 08:53 am Sale |
2024-01-09 | 13G | Icosavax, Inc. ICVX |
FMR CORP | 2,240,524 4.506% |
-2,644,847 (-54.14%) |
Filing History |
| 2023-11-24 3:20 pm Sale |
2023-11-17 | 13D | Icosavax, Inc. ICVX |
Adams Street Partners, LLC | 2,095,087 4.200% |
-122,531 (-5.53%) |
Filing History |
| 2023-07-25 4:18 pm Purchase |
2023-05-25 | 13G | Icosavax, Inc. ICVX |
TCG Crossover GP I, LLC | 3,703,704 7.500% |
3,703,704 (New Position) |
Filing History |
| 2023-06-12 6:45 pm Sale |
2023-05-31 | 13D | Icosavax, Inc. ICVX |
Adams Street Partners, LLC | 2,217,618 5.400% |
-398,951 (-15.25%) |
Filing History |
| 2023-06-05 4:25 pm Purchase |
2023-05-25 | 13G | Icosavax, Inc. ICVX |
Citadel Advisors LLC | 2,189,469 5.300% |
2,189,469 (New Position) |
Filing History |
| 2023-05-30 5:00 pm Purchase |
2023-05-25 | 13D | Icosavax, Inc. ICVX |
RA Capital Management, L.P. | 5,985,843 12.500% |
206,496 (+3.57%) |
Filing History |
| 2023-02-14 06:10 am Sale |
2022-12-31 | 13G | Icosavax, Inc. ICVX |
NanoDimension III L.P. | 1,261,658 3.200% |
-1,488,336 (-54.12%) |
Filing History |
| 2023-02-09 10:31 am Purchase |
2022-12-31 | 13G | Icosavax, Inc. ICVX |
PLATINUM ASSET MANAGEMENT LTD | 2,249,711 5.250% |
2,249,711 (New Position) |
Filing History |
| 2023-01-10 4:02 pm Purchase |
2022-12-31 | 13G | Icosavax, Inc. ICVX |
T. Rowe Price Investment Management, Inc. | 4,463,525 11.200% |
4,463,525 (New Position) |
Filing History |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Icosavax, Inc. ICVX |
FMR CORP | 4,885,371 12.243% |
4,885,371 (New Position) |
Filing History |
| 2022-12-21 5:16 pm Sale |
2022-12-15 | 13D | Icosavax, Inc. ICVX |
Adams Street Partners, LLC | 2,616,569 6.600% |
-775,823 (-22.87%) |
Filing History |
| 2022-02-28 4:02 pm Purchase |
2021-08-02 | 13D | Icosavax, Inc. ICVX |
Qiming U.S. Healthcare GP II LLC | 3,523,561 9.000% |
3,523,561 (New Position) |
Filing History |